News and Press Releases Search About the CF Foundation Research Our Research Approach Advocacy Coronavirus (COVID-19) Clinical Trials Antibiotics CFTR Modulators Drug Pipeline Fitness Get Involved Health Care Reform Medications Patient Registry (-) Infections (-) 2021 2007 News Infections CF Foundation Invests $3.5 Million in Pulmocide for Development of Novel Antifungal Treatment for Lung Transplant Recipients The treatment has the potential to prevent Aspergillus fungal infections in people who have had a lung transplant. Dec. 6, 2021 | 4 min read